tool name

close
tool goes here

FDA warning public of online-pharmacy risk

The Food and Drug Administration is warning U.S. consumers that the vast majority of Internet pharmacies are fraudulent and likely are selling counterfeit drugs that could harm them.

Published: Sept. 29, 2012 at 12:05 a.m. PDT
0 comments

The Food and Drug Administration is warning U.S. consumers that the vast majority of Internet pharmacies are fraudulent and likely are selling counterfeit drugs that could harm them.

The agency on Friday launched a national campaign, called BeSafeRx, to alert the public to the danger, amid evidence that more people are shopping for their medicine online, looking for savings and convenience.

Instead, they’re likely to get fake drugs that are contaminated, are past their expiration date or contain no active ingredient, the wrong amount of active ingredient or even toxic substances such as arsenic and rat poison. They could sicken or kill people, cause them to develop a resistance to their real medicine, cause new side effects or trigger harmful interactions with other medications being taken.

“Our goal is to increase awareness,” FDA Commissioner Dr. Margaret Hamburg said, “not to scare people away from online pharmacies. We want them to use appropriate pharmacies.”

That means pharmacies that are located in the U.S., are licensed by the pharmacy board in the patient’s state and have a licensed pharmacist available to answer questions.

In addition, the pharmacy must require a valid doctor’s prescription for the medicine. Online drugstores that claim none is needed, or that the site’s doctor can write a prescription after the customer answers some questions, are breaking the law.

Research by the National Association of Boards of Pharmacy, which represents the state pharmacy boards, found that of thousands of online pharmacies it reviewed, only about 3 percent follow state and federal laws. In fact, the group’s website lists only a few dozen Internet pharmacies that it has verified are legitimate and following the rules.

Many consumers don’t know that.

An Internet survey, conducted by the FDA in May, questioned 6,090 adults. It found that nearly one in four Internet shoppers has bought prescription drugs online, and nearly three in 10 said they weren’t confident they could do so safely.

The campaign comes after some high-profile cases of counterfeit drugs reaching American patients earlier this year.

JOIN THE DISCUSSION | Register here

We welcome comments. Please keep them civil, short and to the point. ALL CAPS, spam, obscene, profane, abusive and off topic comments will be deleted. Repeat offenders will be blocked. Thanks for taking part — and abiding by these simple rules. A thorough explanation of rules of conduct can be found in our Terms of Service. If you have any questions, including why your comment may not be showing immediately after you submit it, be sure to visit the commenting FAQ.

CONTESTS

Similar stories

  • FDA has safety concerns with Merck insomnia drug

    Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

  • Senate pushes bill to regulate compound pharmacies

    Senate lawmakers are pushing ahead with a bill that would bring new federal oversight to large specialty pharmacies like the one that triggered a deadly meningitis outbreak last year.

  • Vermont is 4th state to legalize assisted suicide

    After years of debate, Vermont became the fourth state in the country Monday to allow doctors to prescribe lethal doses of medicine to terminally ill patients seeking to end their lives.

  • Should doctors get random drug tests?

    What if you're doctor smoked marijuana and then performed surgery on you?

  • Generic Lipitor from India recalled

    TRENTON, N.J. — Ranbaxy Pharmaceuticals has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once led U.S. regulators to bar imports of the Indian company’s medicines.